MDxHealth Gets CLIA OK for Lab | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today said that it has received CLIA certification for its laboratory in Irvine, Calif.

The Liege, Belgium-based firm also said that the lab has passed inspection by the California Department of Health and is now fully licensed and operational.

MDxHealth plans to offer epigenetic diagnostic products for a number of cancer indications. Its first assay, Prostate ConfirmMDx will be launched in the first half of this year, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.